FIELD: chemistry.
SUBSTANCE: invention relates to ethyl 6-((2-chloro-4-fluorobenzyl)sulfonyl)-3-hydroxycyclohex-1-ene-1-carboxylate or its optical isomer, having excellent action, inhibiting signal transmission by Toll-like receptor 4 (TLR4).
EFFECT: cyclic connection is proposed.
12 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
| USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF, OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY OR PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY | 2019 |
|
RU2783733C1 |
| 1-SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE, BASED ON THEM PHARMACEUTICAL COMPOSITION AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2468010C2 |
| COMPOSITIONS AND METHODS OF TREATING COLITIS | 2010 |
|
RU2518416C2 |
| HETEROCYCLIC COMPOUND | 2018 |
|
RU2791533C2 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| HETEROCYCLIC COMPOUND | 2018 |
|
RU2780892C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| PYRROLO[3,2-B]PYRIDINE DERIVATIVE USEFUL AS A MUSCARINE ACETYLCHOLINE RECEPTOR MODULATOR (mAChR)M1 (mAChR M1) | 2014 |
|
RU2688938C2 |
| USING COMPOUNDS BINDING TO SIGMA RECEPTOR LIGANDS FOR TREATING NEUROPATHIC PAIN PROGRESSION CAUSED BY CHEMOTHERAPY | 2009 |
|
RU2537226C2 |
